FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc., effectively updating its labeling under an existing NDA/ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)